Columnist G Shellye Horowitz shares tips you can use to support a loved one who may be feeling anxiety due to concerns about hemophilia.

Prenatal testing - if a pregnant woman has a history of hemophilia, a hemophilia gene test can be done during pregnancy. A sample of placenta is removed from the uterus and tested.

Hemophilia A follows an X-linked recessive inheritance pattern, meaning the altered gene resides on the X chromosome. This genetic arrangement explains several characteristic patterns observed in ...

Still, medications to treat hemophilia on average cost more than $270,000 annually per patient, according to a 2015 Express Scripts report, and they can easily soar past $1 million annually.

Over 5 years of treatment in hemophilia B patients, gene therapy research shows sustained factor IX activity and safety.

People with severe hemophilia A are at risk for prolonged bleeding events that can cause serious complications. To prevent these bleeding events, most people with this condition get injections of ...

In the hemophilia example, he said, a company might have to demonstrate, after a product is on the market, that it actually does reduce bleeding.

Pfizer Inc. (PFE) on Thursday said that its therapy Hympavzi demonstrated improvement in bleeding outcomes for adults and adolescents living with hemophilia A or B with inhibitors in a late-stage ...

Hemophilia, von Willebrand disease, anemia, leukemias, or a low platelet count can cause bruising. A person should contact a doctor if they are concerned about their bruising. Bruising is one of ...

The Food and Drug Administration (FDA) has approved Alhemo ® (concizumab-mtci) injection for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric ...

The FDA is also considering another hemophilia B gene therapy for approval in adults -- fidanacogene elaparvovec, which contains a bio-engineered adeno-associated virus capsid and a high-activity ...

Pfizer’s hemophilia A gene therapy reduced annualized bleeding rates in a Phase 3 clinical trial, setting the stage for discussions with regulators. However, the market for such one-time ...